We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In this article, we are going to take a look at where Zoetis Inc. (NYSE:ZTS) stands against the other best pharma stocks to buy according to hedge funds. The US pharmaceutical sector is ...

Investors in Zoetis Inc (Symbol: ZTS) saw new options begin trading today, for the June 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay ...

Zoetis (ZTS) closed at $170.37 in the latest trading session, marking a +1.87% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.55%. At the same time, the Dow added 0.52% ...

In its fourth quarter 2024 investor letter, Polen Focus Growth Strategy emphasized stocks such as Zoetis Inc. (NYSE:ZTS). Zoetis Inc. (NYSE: ZTS) is involved in the research, development ...

In its fourth quarter 2024 investor letter, Brown Advisors Global Leaders Strategy emphasized stocks such as Zoetis Inc. (NYSE:ZTS). Zoetis Inc. (NYSE: ZTS) is involved in the research ...

Against this backdrop, investors could scoop up shares of fundamentally stable pet industry stocks, Zoetis Inc. (ZTS), Chewy, Inc. (CHWY) and Trupanion, Inc. (TRUP), which are well positioned to ...

Below is Validea's guru fundamental report for ZOETIS INC (ZTS). Of the 22 guru strategies we follow, ZTS rates highest using our P/B Growth Investor model based on the published strategy of ...

Welcome to the Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast for Zoetis. Hosting the call today is Steve Frank, Vice President of Investor Relations for Zoetis ...